Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004
The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002
Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006
Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
Sputum color as a marker for bacterial infection in severe acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004
Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005
Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016
Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Lung function in patients with different infecting agents caused acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003
The relation of sputum color to bacterial load in exacerbations of COPD Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016
Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
The role of bronchial bacterial infection/colonization in acute exacerbation of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018
Relationship between proteases/anti-proteases system in induced sputum and spirometry testing in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 634s Year: 2006
Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease? Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Correlation between sputum colour and isolation of an infecting organism in patients with acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections Year: 2007